Competition And Patent Law In The Pharmaceutical Sector

Author: Gabriella Muscolo
ISBN: 9789041159274
Size: 18.33 MB
Format: PDF, ePub, Mobi
View: 4747
Download Read Online
This book, the first to deal with this issue on a global basis, tackles the clashes of case law by Courts and antitrust enforcement by competition authorities that undermine the predictability of solutions to this problem and increase the ...

Rethinking Intellectual Property

Author: Gustavo Ghidini
Publisher: Edward Elgar Publishing
ISBN: 1783478012
Size: 43.22 MB
Format: PDF, ePub
View: 5988
Download Read Online
Open Questions after Huawei/ZTE', European Competition Law Review, 2016, 33
; K. Henningsson, 'Injunctions for Standard-essential Patents under FRAND
Commitments: A Balanced, Royalty-oriented approach', IIC, 2016, 438; ...
Competition and Patent Law in the Pharmaceutical Sector: An International
Perspective, Kluwer Law International, 2016, 85; G. Ghidini, G. Cavani, and P. F.
Piserà, 'Abuse of Patent Rights and Abuse of Dominant Position: The Pfizer Case'
, in G. Pitruzzella ...

Competition Law And Patents

Author: Irina Haracoglou
Publisher: Edward Elgar Publishing
ISBN: 1848440111
Size: 66.11 MB
Format: PDF, ePub
View: 5828
Download Read Online
Baily, M. (1972), R&D Costs and Returns: The US Pharmaceutical Industry, 80
Journal of Political Economy 70. Balance, R., Pogany, J. and Forstner, H. (1992),
The World's Pharmaceutical Industries: An International Perspective on
Innovation, Competition and Policy, UNIDO. Baldwin, J.R., Hanel, P. and
Sabourin, D. (2000), Determinants of Innovative Activity in Canadian
Manufacturing Firms: The Role ofIPRs, Statistics Canada, Analytical Studies
Branch series Research Papers No.

Research Handbook On Intellectual Property And The Life Sciences

Author: Duncan Matthews
Publisher: Edward Elgar Publishing
ISBN: 1783479450
Size: 62.80 MB
Format: PDF
View: 6039
Download Read Online
This disparity is due to the focus of Japanese drug manufacturers on the
domestic market, with protections from competition with foreign drug
manufacturers through the government's capital control policy. ... Moreover,
pharmaceutical products were excluded from patent eligible subject matter until
the Japanese Patent Act (JPA) was revised in 1976. ... (eds), The Pharmaceutical
Sector Between Patent Law and Competition Law: An International Perspective (
Wolters Kluwer 2016).

Pharmaceutical Innovation Competition And Patent Law

Author: Josef Drexl
Publisher: Edward Elgar Publishing
ISBN: 0857932462
Size: 78.45 MB
Format: PDF, ePub, Docs
View: 6623
Download Read Online
While the history of modern patent laws attests that the patent law has often been
used as a policy instrument to foster industrial development in particular
technological sectors, the contemporary patent laws seem to be firmly
established as a system of intangible property, based on neutrally applicable
norms, with the principle of nondiscrimination among industry sectors. In most
countries, the procedure of patent granting is based on objective administrative
examination of subjective ...

Research Handbook On International Competition Law

Author: Ariel Ezrachi
Publisher: Edward Elgar Publishing
ISBN: 0857934805
Size: 31.69 MB
Format: PDF
View: 7221
Download Read Online
The Research Handbook on International Competition Law brings together leading academics, practitioners and competition officials to discuss the most recent developments in international competition law and policy.

Intellectual Property Enforcement

Author: Xuan Li
Publisher: Edward Elgar Publishing
ISBN: 1848449259
Size: 37.97 MB
Format: PDF, Kindle
View: 647
Download Read Online
International Perspectives Xuan Li, Carlos Maria Correa ... limitations to IP
protection, whether in the form of requirements for the granting of IP rights,35
delineations of their scope36 or interfaces with other areas of law such as
competition law.37 On the international level, an overly broad definition of '
counterfeiting' or 'piracy' may limit (via extensive measures to combat the former)
legitimate generic competition, for example in the pharmaceutical sector (Mathew
, 2008; Narendranath, ...

Research Handbook On Intellectual Property Exhaustion And Parallel Imports

Author: Irene Calboli
Publisher: Edward Elgar Publishing
ISBN: 1783478713
Size: 24.30 MB
Format: PDF, Mobi
View: 3280
Download Read Online
(5) Summary of the GlaxoSmithKline cases With the GlaxoSmithKline decisions,
EU competition law has reached a more balanced approach to the application of
competition law to restraints of competition on parallel trade in pharmaceuticals.
The argument is that such restraints may enhance the ability of R&D-oriented
pharmaceutical companies to compete with each other in innovation. The
problem remains that, in individual cases, it will be extremely difficult or even
practically ...

Intellectual Property And Sustainable Development

Author: Ricardo Meléndez-Ortiz
Publisher: Edward Elgar Publishing
ISBN: 1849803455
Size: 10.97 MB
Format: PDF
View: 4797
Download Read Online
Intellectual property rights are multifaceted and affect sectors that differ markedly
in how innovation takes place, how firms compete and how new products or
technologies are used. To be concrete, this chapter is quite selective in focusing
on the role of competition law – as a key 'horizontal' complementary policy – and,
as an illustration of sector-specific policies, on the role of price and advertising
regulations in the pharmaceutical sector. COMPETITION LAW From an economic

Science Public Policy

Size: 46.66 MB
Format: PDF, Mobi
View: 6141
Download Read Online
Patenting software? A judicial and socio-economic analysis. international Review
of Intellectual Property and Competition Law, 36(6), 615-646. Hopkins, M M, S
Mahdi. P Patel and S M Thomas 2007. DNA patenting: the end of an era? Nature
... European Competition Law Review, 117. Jacob, R 2008. Patents and
pharmaceuticals. Paper given on 29 November 2008 at the presentation of the
Directorate-General of Competition_s Preliminary Report on the Pharma-sector